|
[1]
|
Xu, T., Zhou, X., Shen, C. and Hu, C. (2018) Suggestions for Surveillance and Radiation Strategy in Nasopharyngeal Carcinoma Treated with IMRT: Based on Hazard-Rate and Patterns of Recurrence. Oral Oncology, 76, 61-67. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., et al. (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 74, 229-263. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Au, K.H., Ngan, R.K.C., Ng, A.W.Y., Poon, D.M.C., Ng, W.T., Yuen, K.T., et al. (2018) Treatment Outcomes of Nasopharyngeal Carcinoma in Modern Era after Intensity Modulated Radiotherapy (IMRT) in Hong Kong: A Report of 3328 Patients (HKNPCSG 1301 Study). Oral Oncology, 77, 16-21. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Xiao, X., Zou, S., Chen, Y., Guo, R., Tang, L., Sun, Y., et al. (2024) Patterns and Prognosis of Local Recurrence of Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy. Journal of Cancer, 15, 456-465. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Li, C. and Duan, J. (2021) Effect of High-Quality Nursing Intervention on Psychological Emotion, Life Quality and Nursing Satisfaction of Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy. American Journal of Translational Research, 13, 4928-4938.
|
|
[6]
|
Zhou, X., Zhu, J., Zhou, C., Wang, W., Ding, W., Chen, M., et al. (2023) Failure Patterns of Locoregional Recurrence after Reducing Target Volumes in Patients with Nasopharyngeal Carcinoma Receiving Adaptive Replanning during Intensity-Modulated Radiotherapy: A Single-Center Experience in China. Radiation Oncology, 18, Article No. 190. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Huang, Y., Zhou, J., Zhan, Z., Ke, L., Xia, W., Cao, X., et al. (2023) Tumor Residue in Patients with Stage II-IVA Nasopharyngeal Carcinoma Who Received Intensity-Modulated Radiation Therapy: Development and Validation of a Prediction Nomogram Integrating Postradiotherapy Plasma Epstein-Barr Virus Deoxyribonucleic Acid, Clinical Stage, and Radiotherapy Dose. BMC Cancer, 23, Article No. 410. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Tian, Y., Huang, W., Zeng, L., Bai, L., Han, F. and Lan, Y. (2022) The Failure Patterns of Nasopharygeal Carcinoma after Intensity-Modulated Radiotherapy and Implications for Surveillance. Cancer Management and Research, 14, 2813-2823. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Tang, L., Guan, Z. and Xu, M. (2022) The Role of Circulating Tumor Cells in the Prognosis of Local Recurrence and Local Residual Nasopharyngeal Carcinoma Undergoing Endoscopic Resection. Journal of Oncology, 2022, Article ID: 1453792. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Stoker, S.D., van Diessen, J.N.A., de Boer, J.P., Karakullukcu, B., Leemans, C.R. and Tan, I.B. (2013) Current Treatment Options for Local Residual Nasopharyngeal Carcinoma. Current Treatment Options in Oncology, 14, 475-491. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Poh, S.S., Soong, Y.L., Sommat, K., Lim, C.M., Fong, K.W., Tan, T.W., et al. (2021) Retreatment in Locally Recurrent Nasopharyngeal Carcinoma: Current Status and Perspectives. Cancer Communications, 41, 361-370. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Weng, J., Wei, J., Si, J., Qin, Y., Li, M., Liu, F., et al. (2017) Clinical Outcomes of Residual or Recurrent Nasopharyngeal Carcinoma Treated with Endoscopic Nasopharyngectomy Plus Chemoradiotherapy or with Chemoradiotherapy Alone: A Retrospective Study. PeerJ, 5, e3912. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Lv, J., Zhou, G., Li, J., Tang, L., Mao, Y., Lin, A., et al. (2017) Magnetic Resonance Imaging-Detected Tumor Residue after Intensity-Modulated Radiation Therapy and Its Association with Post-Radiation Plasma Epstein-Barr Virus Deoxyribonucleic Acid in Nasopharyngeal Carcinoma. Journal of Cancer, 8, 861-869. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Zhou, P., Zhou, J., Lian, C., Yu, Y., Zhou, R., Lin, Q., et al. (2023) Residual Plasma Epstein-Barr Virus DNA after Intensity-Modulated Radiation Therapy Is Associated with Poor Outcomes in Nasopharyngeal Carcinoma. Future Oncology, 19, 2227-2235. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Li, W., Wu, H., Lv, S., Hu, X., Liang, H., Liu, G., et al. (2021) Assessment of Survival Model Performance Following Inclusion of Epstein-Barr Virus DNA Status in Conventional TNM Staging Groups in Epstein-Barr Virus-Related Nasopharyngeal Carcinoma. JAMA Network Open, 4, e2124721. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Kwong, D.L.W., Nicholls, J., Wei, W.I., Chua, D.T.T., Sham, J.S.T., Yuen, P.W., et al. (1999) The Time Course of Histologic Remission after Treatment of Patients with Nasopharyngeal Carcinoma. Cancer, 85, 1446-1453. [Google Scholar] [CrossRef]
|
|
[17]
|
Li, W., Zhang, Y., Liu, X., Tang, L., Tian, L., Guo, R., et al. (2017) Delayed Clinical Complete Response to Intensity-Modulated Radiotherapy in Nasopharyngeal Carcinoma. Oral Oncology, 75, 120-126. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Sham, J.S.T., Wei, W.I., Kwan, W.H., Chan, C.W., Kwong, W.K. and Choy, D. (1990) Nasopharyngeal Carcinoma. Pattern of Tumor Regression after Radiotherapy. Cancer, 65, 216-220. [Google Scholar] [CrossRef]
|
|
[19]
|
Zhang, N., Liang, S., Deng, Y., Lu, R., Chen, H., Zhao, H., et al. (2014) Primary Tumor Regression Speed after Radiotherapy and Its Prognostic Significance in Nasopharyngeal Carcinoma: A Retrospective Study. BMC Cancer, 14, Article No. 136. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Jin, T., Liu, N., Jin, Q., Hua, Y. and Chen, X. (2022) Radiation Dose Escalation for Locally Advanced Nasopharyngeal Carcinoma Patients with Local and/or Regional Residual Lesions after Standard Chemoradiotherapy: A Non-Randomized, Observational Study. Radiation Oncology, 17, Article No. 176. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Murakami, N., Cheng, G., Yoshimoto, S. and Itami, J. (2020) Image-Guided Interstitial Brachytherapy Boost for Nasopharyngeal Carcinoma: Technical Aspects. Journal of Contemporary Brachytherapy, 12, 294-302. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Guinot, J.L., Moya, A., Santos, M.A., Peña, M., Quiles, B., Sanchez-Relucio, J.C., et al. (2020) Should High-Dose-Rate Brachytherapy Boost Be Used in Early Nasopharyngeal Carcinomas? Reports of Practical Oncology & Radiotherapy, 25, 479-483. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Leung, T., Tung, S.Y., Sze, W., Sze, W., Wong, V.Y.W. and O, S. (2000) Salvage Brachytherapy for Patients with Locally Persistent Nasopharyngeal Carcinoma. International Journal of Radiation Oncology Biology Physics, 47, 405-412. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Law, S.C.K., Lam, W., Ng, M., Au, S., Mak, W. and Lau, W. (2002) Reirradiation of Nasopharyngeal Carcinoma with Intracavitary Mold Brachytherapy: An Effective Means of Local Salvage. International Journal of Radiation Oncology Biology Physics, 54, 1095-1113. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Teo, P., Leung, S.F., Choi, P., Lee, W.Y. and Johnson, P.J. (1994) After Loading Radiotherapy for Local Persistence of Nasopharyngeal Carcinoma. The British Journal of Radiology, 67, 181-185. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Kwong, D.L.W., Wei, W.I., Cheng, A.C.K., Choy, D.T.K., Lo, A.T.C., Wu, P.M., et al. (2001) Long Term Results of Radioactive Gold Grain Implantation for the Treatment of Persistent and Recurrent Nasopharyngeal Carcinoma. Cancer, 91, 1105-1113. [Google Scholar] [CrossRef]
|
|
[27]
|
Ren, Y.F., Cao, X.P., Xu, J., Ye, W.J., Gao, Y.H., Teh, B.S., et al. (2013) 3D-Image-Guided High-Dose-Rate Intracavitary Brachytherapy for Salvage Treatment of Locally Persistent Nasopharyngeal Carcinoma. Radiation Oncology, 8, Article No. 165. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Zhang, X., Wu, N., Zhao, Z., Han, D., He, M., Yang, W., et al. (2019) Fibre-Optic Endoscope-Guided Three-Dimensional High-Dose-Rate Interstitial Brachytherapy for Residual Nasopharyngeal Carcinoma after Conventional External Beam Radiotherapy. Journal of Contemporary Brachytherapy, 11, 243-249. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Wan, X., Jiang, R., Xie, F., Qi, Z., Li, A., Ye, W., et al. (2014) Endoscope-Guided Interstitial Intensity-Modulated Brachytherapy and Intracavitary Brachytherapy as Boost Radiation for Primary Early T Stage Nasopharyngeal Carcinoma. PLOS ONE, 9, e90048. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Yue, Q., Zhang, M., Chen, Y., Zheng, D., Chen, Y. and Feng, M. (2018) Establishment of Prognostic Factors in Recurrent Nasopharyngeal Carcinoma Patients Who Received Salvage Intensity-Modulated Radiotherapy: A Meta-Analysis. Oral Oncology, 81, 81-88. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Lee, C., Lee, J., Huang, W., Juan, C., Jen, Y. and Lin, L. (2021) Image-Based Diagnosis of Residual or Recurrent Nasopharyngeal Carcinoma May Be a Phantom Tumor Phenomenon. Medicine, 100, e24555. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Ma, Z., Umezawa, R., Yamamoto, T., Ishikawa, Y., Takahashi, N., Takeda, K., et al. (2021) IMRT Improves Local Control in Patients with Nasopharyngeal Carcinoma Compared with Conventional Radiotherapy: Propensity Score-Matched Analysis. Japanese Journal of Clinical Oncology, 51, 1444-1451. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Du, T., Xiao, J., Qiu, Z. and Wu, K. (2019) The Effectiveness of Intensity-Modulated Radiation Therapy versus 2D-RT for the Treatment of Nasopharyngeal Carcinoma: A Systematic Review and Meta-analysis. PLOS ONE, 14, e0219611. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Liang, S., Zhang, N., Chen, D., Yang, X., Chen, B., Zhao, H., et al. (2019) Prognostic Value of Gross Tumor Regression and Plasma Epstein Barr Virus DNA Levels at the End of Intensity-Modulated Radiation Therapy in Patients with Nasopharyngeal Carcinoma. Radiotherapy and Oncology, 132, 223-229. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Fei, Z., Xu, T., Qiu, X., Li, M., Chen, T., Li, L., et al. (2021) Significance of Boost Dose for T4 Nasopharyngeal Carcinoma with Residual Primary Lesion after Intensity-Modulated Radiotherapy. Journal of Cancer Research and Clinical Oncology, 147, 2047-2055. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Lu, T., Mai, W., Teh, B.S., Zhao, C., Han, F., Huang, Y., et al. (2004) Initial Experience Using Intensity-Modulated Radiotherapy for Recurrent Nasopharyngeal Carcinoma. International Journal of Radiation Oncology Biology Physics, 58, 682-687. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Chua, D.T.T., Sham, J.S.T., Leung, L.H.T. and Au, G.K.H. (2005) Reirradiation of Nasopharyngeal Carcinoma with Intensity-Modulated Radiotherapy. Radiotherapy and Oncology, 77, 290-294. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Karam, I., Huang, S.H., McNiven, A., Su, J., Xu, W., Waldron, J., et al. (2015) Outcomes after Reirradiation for Recurrent Nasopharyngeal Carcinoma: North American Experience. Head & Neck, 38, E1102-E1109. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Chen, Y., Ismaila, N., Chua, M.L.K., Colevas, A.D., Haddad, R., Huang, S.H., et al. (2021) Chemotherapy in Combination with Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline. Journal of Clinical Oncology, 39, 840-859. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Xiao, J. and Zhen, X. (2010) Stereotactic Radiotherapy—An Approach to Improve Local Control of Nasopharyngeal Carcinoma. Chinese Journal of Cancer, 29, 123-125. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
肖建平, 徐国镇. 立体定向放射治疗: 提高鼻咽癌局部控制的有效方法[J]. 癌症, 2010, 29(2): 129-131.
|
|
[42]
|
Liu, F., Xiao, J.P., Xu, Y.J., et al. (2012) Fractionated Stereotactic Radiotherapy with Vagina Carotica Protection Technique for Local Residual Nasopharyngeal Carcinoma after Primary Radiotherapy. Chinese Medical Journal (England), 125, 2525-2529.
|
|
[43]
|
Liu, F., Xiao, J., Xu, G., Gao, L., Xu, Y., Zhang, Y., et al. (2013) Fractionated Stereotactic Radiotherapy for 136 Patients with Locally Residual Nasopharyngeal Carcinoma. Radiation Oncology, 8, Article No. 157. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Chua, D.T., Wu, S., Lee, V. and Tsang, J. (2009) Comparison of Single versus Fractionated Dose of Stereotactic Radiotherapy for Salvaging Local Failures of Nasopharyngeal Carcinoma: A Matched-Cohort Analysis. Head & Neck Oncology, 1, Article No. 13. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Chitapanarux, I., Kittichest, R., Tungkasamit, T., Asakit, T., Chomprasert, K., Chakrabandhu, S., et al. (2021) Two-Year Outcome of Concurrent Chemoradiation with Carboplatin with or without Adjuvant Carboplatin/Fluorouracil in Nasopharyngeal Cancer: A Multicenter Randomized Trial. Current Problems in Cancer, 45, Article ID: 100620. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Chen, Y., Liu, X., Zhou, Q., Yang, K., Jin, F., Zhu, X., et al. (2021) Metronomic Capecitabine as Adjuvant Therapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Multicentre, Open-Label, Parallel-Group, Randomised, Controlled, Phase 3 Trial. The Lancet, 398, 303-313. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Cao, X., Huang, H., Liang, C., Lin, Z., Zhou, J., Chen, X., et al. (2024) Toripalimab plus Capecitabine in the Treatment of Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm Phase 2 Trial. Nature Communications, 15, Article No. 949. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Mai, H., Chen, Q., Chen, D., Hu, C., Yang, K., Wen, J., et al. (2021) Toripalimab or Placebo plus Chemotherapy as First-Line Treatment in Advanced Nasopharyngeal Carcinoma: A Multicenter Randomized Phase 3 Trial. Nature Medicine, 27, 1536-1543. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Ruan, X., Liang, J., Pan, Y., Cai, R., Zhang, R.J., He, Z., et al. (2021) Apatinib for the Treatment of Metastatic or Locoregionally Recurrent Nasopharyngeal Carcinoma after Failure of Chemotherapy: A Multicenter, Single‐Arm, Prospective Phase 2 Study. Cancer, 127, 3163-3171. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
张力. 鼻咽癌的综合治疗进展[J]. 肿瘤防治研究, 2019, 46(8): 667-671.
|
|
[51]
|
Jiang, S., Han, L., Liang, L. and Long, L. (2022) Development and Validation of an MRI-Based Radiomic Model for Predicting Overall Survival in Nasopharyngeal Carcinoma Patients with Local Residual Tumors after Intensity-Modulated Radiotherapy. BMC Medical Imaging, 22, Article No. 174. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
He, Y., Zhou, Q., Shen, L., Zhao, Y., Lei, M., Wei, R., et al. (2015) A Retrospective Study of the Prognostic Value of MRI-Derived Residual Tumors at the End of Intensity-Modulated Radiotherapy in 358 Patients with Locally-Advanced Nasopharyngeal Carcinoma. Radiation Oncology, 10, Article No. 89. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Xu, M., Liu, C., Mi, J.L. and Wang, R.S. (2020) A Nomogram for the Prognosis of Nasopharyngeal Carcinoma with MR Imaging-Detected Tumor Residue at the End of Intensity-Modulated Radiotherapy. Cancer Management and Research, 12, 3835-3844. [Google Scholar] [CrossRef] [PubMed]
|